Stereotactic Core Biopsy Following Screening Mammography: A Danish Retrospective National Cohort Study ()
Affiliation(s)
1Department of Radiology, Aarhus University Hospital, Aarhus, Denmark.
2Department of Plastic Surgery, Odense University Hospital, Odense, Denmark.
3Research Unit of General Practice, University of Southern Denmark, Odense, Denmark.
4Department of Radiology & Mammography, SLB Vejle Hospital, Vejle, Denmark.
5Department of Pathology, SVS Esbjerg Finsensgade, Esbjerg, Denmark.
6Department of Breast Surgery, SLB Vejle Hospital, Vejle, Denmark.
ABSTRACT
Background: Since introducing stereotactic core biopsy (SCB) on breast lesions in Denmark, no national follow-up of the procedure has been executed. Purpose: To evaluate performance of SCB in Danish mammography screening. 3 areas were selected for evaluation: diagnostic value of SCB, performance of the Danish 7-tier mamma-radiological classifications system, DKBI-RADS, and diagnostic delay for SCB-diagnosis. Materials & Methods: Danish retrospective national cohort study including 2195 screening patients undergoing SCB. Study period: 01.01.2010 to 30.09.2012. Patients were identified from The Danish National Patient Register. Pathology-data were obtained from the Danish Pathology Database. Radiological-data according to DKBI-RADS were recorded. Diagnostic delay from clinical mammography until diagnosis was registered. Results: 173 SCBs indicated cancer; all operated with 3 cases finalized as benign. 1296 cases were determined benign with diagnostic surgery in 81 cases of which 31 were concluded pre-malignant/malignant. Correlation between DKBI-RADS and pathology diagnosis: 329 of 485 DKBI-RADS3, 227 of 450 DKBI-RADS4 were benign. 4 of 16 DKBI-RADS5 were benign. The diagnostic value of pre-malignant/malignant SCB related to results from surgery showed 94.4% sensitivity and a positive predictive value of 93.9%. Median diagnostic-time of single-biopsy was 13 days. Conclusion: The performance of SCB in Denmark is comparable to international studies regarding the diagnostic value of malignant SCB. The study indicates that DKBI-RADS classifications are not used consistently regarding micro-calcifications selected in screening-mammographies. Diagnostic delay is acceptable, subject to EUSOMA specifications, regarding single-biopsy.
Share and Cite:
Redsted, S. , Nguyen, Q. , Christensen, R. , Myrtue, G. , Caterino, T. and Lautrup, M. (2018) Stereotactic Core Biopsy Following Screening Mammography: A Danish Retrospective National Cohort Study.
International Journal of Clinical Medicine,
9, 341-355. doi:
10.4236/ijcm.2018.95030.
Cited by
No relevant information.